Revvity | PKI - Interest Income


Revvity reported $6.3M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Agilent USD 15M 2M Dec/2025
Align Technology USD 3.91M 710K Mar/2026
Bio Techne USD 897K 74K Dec/2025
Bio-Rad Laboratories USD 21M 10M Mar/2026
Bruker USD 4.4M 1.5M Sep/2025
Celltrion KRW 779M 157.66M Mar/2026
Charles River Laboratories USD -0.03 0.27 Jun/2026
Danaher USD 1.23 27M Jun/2026
Dentsply International USD 4M 1000K Mar/2025
Dianthus Therapeutics USD 6.26M 2.61M Mar/2026
Edwards Lifesciences USD 56.3M 17.7M Dec/2025
Illumina USD 1.35 0.48 Jun/2026
Intuitive Surgical USD 85.1M 6.2M Mar/2026
IQVIA Holdings USD 7M 3M Jun/2026
Kangmei Pharma CNY 2.44M 635.78K Mar/2026
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Medical Developments International AUD 174K 31K Dec/2024
Myriad Genetics USD 300K 0 Mar/2025
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 10.56M 9.44M Mar/2026
Quest Diagnostics USD 2M 1000K Mar/2026
Quidel USD -1.35 500K Mar/2026
Repligen USD 7.31M 979K Mar/2025
Revvity USD 6.3M 552K Mar/2026
Sartorius EUR 14.8M 5.3M Jun/2026
Thermo Fisher Scientific USD 233M 25M Mar/2026
Tilray USD 12.83M 20.19M May/2024
Waters USD 6M 331K Mar/2026
Zealand Pharma A/S 74M 28.41M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M Mar/2026